Dopamine Agonists: US FDA Orders Safety Labeling Changes But Not Boxed Warnings

 
• By Sue Sutter
  
Warning sign with exclamation mark on striped caution tape
US FDA is broadening some dopamine agonist warning language to patients with restless legs syndrome. • Source: Shutterstock

More from Drug Safety

More from Pink Sheet